$2.8215
0.0415[1.49%]
Last update: 9:26AM Get Real Time Here
Regulus Therapeutics
(NASDAQ:RGLS)Regulus Therapeutics Stock (NASDAQ:RGLS), Quotes and News Summary
Regulus Therapeutics Stock (NASDAQ: RGLS) stock price, news, charts, stock research, profile.
| Open | $2.700 |
| Close | - |
| Volume / Avg. | 377.637K / 3.002M |
| Day Range | 2.575 - 2.780 |
| 52 Wk Range | 1.080 - 3.790 |
| Market Cap | $184.710M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 54 |
| Short Interest | 8.9% |
| Days to Cover | 6.11 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Regulus Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Regulus Therapeutics (RGLS) stock?
You can purchase shares of Regulus Therapeutics (NASDAQ: RGLS) through any online brokerage.
Who are Regulus Therapeutics's (RGLS) competitors?
Other companies in Regulus Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), GlycoMimetics (NASDAQ:GLYC) and Adicet Bio (NASDAQ:ACET).
What is the target price for Regulus Therapeutics (RGLS) stock?
The latest price target for Regulus Therapeutics (NASDAQ: RGLS) was reported by HC Wainwright & Co. on Monday, March 25, 2024. The analyst firm set a price target for 9.00 expecting RGLS to rise to within 12 months (a possible 244.83% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Regulus Therapeutics (RGLS)?
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $2.61 last updated Today at April 16, 2024 at 1:56 PM EDT.
Does Regulus Therapeutics (RGLS) pay a dividend?
There are no upcoming dividends for Regulus Therapeutics.
When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?
Regulus Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Regulus Therapeutics (RGLS) going to split?
There is no upcoming split for Regulus Therapeutics.
What sector and industry does Regulus Therapeutics (RGLS) operate in?
Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.